FDA NDC Directory · JSON-LD · Markdown

Irinotecan Hydrochloride

NDC 60505-6272 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA203380
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsIRINOTECAN HYDROCHLORIDE (20 mg/mL)
Marketing started20230701
Package count1

External sources

Source: openFDA. Public-domain (CC0).